This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Original Article -
Short-term effects of di-(2-ethylhexyl) phthalate on testes,
liver, kidneys and pancreas in mice
Yumi Miura1, Munekazu
Naito1, Maira Ablake2, Hayato
Terayama1, Shuang-Qin Yi1, Ning
Qu1, Lin-Xian Cheng1, Shigeru
Suna3, Fumihiko Jitsunari3, Masahiro
Itoh1
1Department of Anatomy, Tokyo Medical University, Tokyo 160-8402, Japan
2Department of Histology and Embryology, Xin Jiang Medical University, Xinjiang 830001, China
3Department of Hygiene and Public Health, Faculty of Medicine, Kagawa University, Kagawa 761-0783, Japan
Abstract
Aim: To determine the biochemical effect of di-(2-ethylhexyl) phthalate (DEHP) on testes, liver, kidneys and
pancreas on day 10 in the process of degeneration of the seminiferous epithelium.
Methods: Diets containing 2% DEHP were given to male Crlj:CD1(ICR) mice for 10 days. The dose of DEHP was 0.90 ± 0.52 mg/mouse/day. Their
testes, livers, kidneys and pancreata were examined for detection of mono-(2-ethylhexyl) phthalate (MEHP), nitrogen
oxides (NOx) produced by peroxidation of nitric oxide (NO) with free radicals, and lipid peroxidation induced by the
chain reaction of free radicals. Results: Histological observation and serum analysis showed the presence of severe
spermatogenic disturbance, Leydig cell dysfunction, liver dysfunction and dehydration. Unexpectedly, the
concentration of MEHP in the testes was extremely low compared with that in the liver. However, the concentration of the
NOx in the testes was as high as the hepatic concentration. Furthermore, free radical-induced lipid peroxidation was
histochemically detected in the testes but not in the liver.
Conclusion: The results indicate that DEHP-induced
aspermatogenesis is caused by the high sensitivity of the testicular tissues to MEHP rather than the specific
accumulation or uptake of circulating MEHP into the
testes. (Asian J Androl 2007 Mar; 9: 199_205)
Keywords: phthalate; nitrogen oxide; free radical; testis
Correspondence to: Dr Munekazu Naito, Department of Anatomy, Tokyo Medical University, Shinjuku 6-1-1, Shinjuku-ku, Tokyo
160-8402, Japan.
Tel: +81-3-3351-6141 Fax: +81-3-3341-1137
E-mail: anatomy@tokyo-med.ac.jp
Received: 2006-01-24 Accepted: 2006-06-05
DOI: 10.1111/j.1745-7262.2007.00220.x
1 Introduction
Experimentally, di-(2-ethylhexyl) phthalate (DEHP),
widely used as a plasticizer for synthetic polymers, is
known to induce testicular atrophy with hepatomegaly
in mice and rats [1, 2]. After oral exposure, most DEHP
is rapidly metabolized in the gut into mono-(2-ethylhexyl)
phthalate (MEHP), the active metabolite inducing testicular
atrophy [1]. Many biochemical studies have shown
that the concentrations of testosterone, zinc, ascorbic
acid and glutathione are decreased in both testes and sera
of DEHP-treated animals [3, 4]. However, the details of
mechanisms of the spermatogenic disturbance caused
by DEHP remain unclear. There is speculation that the
production of free-radicals might injure the seminiferous
epithelium in DEHP-treated animals. Actually, Kasahara
et al. [4] recently showed that oral administration of DEHP
increased the generation of reactive oxygen species (ROS)
(O2- and H2O2) with concomitant decreases in glutathione
and ascorbic acid in the rat testes. Nitric oxide (NO) is
also a free radical, and is a potential biological mediator
that functions at low concentration as a signal in many
diverse physiological processes, but it might cause DNA
damage and cell death at high concentration [5, 6].
However, so far there has been no report on nitrogen
oxides (NOx) in DEHP-treated animals. Our previous
study showed that feeding mice with diets containing
2% DEHP induced focal degeneration of the
seminiferous epithelium from day 5 and depletion of almost all
germ cells by day 15 [7]. The aim of the present study
is to compare the NOx generation, the MEHP
distribution and lipid peroxidation in the testis with those in the
liver, kidney and pancreas in 2% DEHP-treated mice.
2 Materials and methods
2.1 Animals
Male Crlj:CD1(ICR) mice (6-week old) were purchased from Charles River (Kanagawa, Japan) and kept
in the Laboratory Animal Center of Tokyo Medical
University for 1 week. They were maintained at 22_24ºC
and 50%_60% relative humidity with a 12 h : 12 h light :
dark cycle. The approval of the Tokyo Medical
University Animal Committee was obtained for the present study.
2.2 Phthalate
DEHP and MEHP (the most toxic metabolite of DEHP)
were purchased from Tokyo Chemical Industries (Tokyo,
Japan). The chemical purity of both DEHP and MEHP
was found to be > 98% on gas-liquid chromatography.
A normal CE-2 diet was purchased from Clea (Tokyo,
Japan), and CE-2 diet containing 2% DEHP was prepared by Oriental Yeast Company (Chiba, Japan). We
used a diet of 2% DEHP because our previous study showed that the diet containing 2%, instead of 1% DEHP,
induced significant aspermatogenesis in rats when given
for 2 weeks [8].
2.3 Experimental design
Seven-week-old male ICR mice were divided into control
(n = 5) and DEHP-treated groups (n = 7). They
were fed with normal diet and diet containing 2% DEHP
for 10 days, respectively. Both the diets and tap water
were freely available. Each mouse ate 4.50 ± 0.56 g and
4.50 ± 0.26 g (mean ± SE) diets in the control and the
2%-DEHP-treated group, respectively. They drank approximately 7 mL water a day. There were no
significant differences in these volumes between the two
groups. On days 0 and 10, the bodyweight of each mouse
was determined. The dose of DEHP was 0.90 ± 0.52
mg/mouse/day. On day 10, all mice were deeply
anesthetized with diethyl ether, and then blood was taken from
the right atrium. Thereafter, the testis, liver, kidney and
pancreas of each mouse were weighed. Organ
weight/body weight (BW) × 100 is presented as the relative
organ weight. The blood samples were allowed to clot and
then centrifuged at 4 500 × g for 15 min at 4ºC. Each
serum sample was kept at _80ºC until it was used.
2.4 Histochemical detection of lipid peroxidation
According to the method of Pompella et
al. [9], lipid peroxidation was histochemically detected to examine the
presence of free radicals-induced tissue injury. The testes,
livers, kidneys and pancreata were removed from the
control and DEHP-treated mice on day 10 under
anesthesia with pentobarbital and then frozen at _80ºC. These
frozen sections, 5 ìm each, were fixed in 90% ethanol for
2 min, and then incubated at 37ºC for 5 min in 0.15
mol/L KCl and 0.05 mol/L Tris-maleate buffer, pH 7.4,
containing an NADPH-Fe system (0.8 mmol/L nicotinamide
adenine dinucleotide phophate [NADPH], 0.1 mmol/L
FeCl3 and 4.5 mmol/L Adenosine diphosphate [ADP]).
The sections were incubated in 0.5 mol/L KCl and 0.05
mol/L Tris-maleate buffer containing 3 mol/L ethylenediaminetetracetic acid (EDTA). The sections
were then stained for 2.5 h in the dark at room
temperature with cold Schiff's reagent. After the reaction, the
sections were washed with three changes of sulfide water
(20 mmol/L K2S2O5 and 0.05 mol/L NHCl) for 5 min and
then counterstained with methyl green. The presence of
lipid peroxide was detected as red-brown granules.
2.5 Biochemical examination of sera
Serum samples were analyzed for testosterone, total
protein, alkaline phosphatase (ALP), glutamic pyruvic
transaminase (GPT), blood urea nitrogen (BUN),
creatinine (CRE), uric acid (UA), sodium (Na) and chlorine
(Cl). The analyses, except that of testosterone, were
carried out with a BMD/Hitachi 704/737 Chemistry
Analyzer (Boehringer Mannheim Diagnostics, Indianapolis,
IN, USA). The concentration of testosterone was
determined by radioimmunoassay according to the method
used by Verjans et al. [10].
2.6 Measurement of mineral components of antioxidant
enzymes in the testes
Analytical grade chemicals and metal standard
solutions were purchased from Wako Pure Chemical
Industries (Osaka, Japan). Samples of the control and
DEHP-treated testes were placed in
polytetrafluoroethylene (PTFE) decontaminated decomposition vessels,
and then 0.5 mL of an acid mixture,
HNO3/HClO4/H2SO
4 (50 : 50 : 1, v/v/v), was added. The vessels were kept
on a heating plate at 140ºC for 4 h and then heated
to 200ºC until almost dry. The residue was dissolved in
2 mL of 0.1 mol/L HCl and then properly diluted. The
concentrations of Fe (a cofactor for catalase or an
active center of Fe-superoxide dismutase [SOD]), Cu and
Zn (active centers of Cu/Zn-SOD) were determined by
"one-drop" flame atomic absorption spectrometry [11].
The analytical instrument used was a Seiko-SAS 7500
model with deuterium background correction (Seiko,
Tokyo, Japan).
2.7 Measurement of MEHP concentrations in
DEHP-treated mice
The MEHP levels in testes, livers, kidneys and pancreata of DEHP-treated mice were determined by
high performance liquid chromatography (HPLC) with
a TOSOH system (TOSOH, Tokyo, Japan). Samples of organs were homogenized in four volumes of 1
mol/L NaOH, and then 250 mg of each homogenate was
mixed with 850 ìL of acetonitrile. The mixtures were
shaken vigorously and then kept in an ultrasonic water
bath for 10 min, and then 10 ìL of
H3PO4 was added. After centrifugation for 10 min at 1 500 ×
g, 40 μL of each supernatant was injected into the HPLC system.
Separation was carried out on a reversed-phase TSK
gel ODS-80TM column (5 ìm beads, 150.0 × 4.6 mm
I.D.; TOSOH, Tokyo, Japan) at room temperature. The
mobile phase comprised a mixture of acetonitrile and
0.1% H3PO4 (60 : 40, v/v). The flow rate was 1.0 mL/min.
The ultraviolet absorbance of the effluent was
monitored at 230 nm [12]. Quantification was carried out
using matrix-matched standards prepared by the
addition of MEHP standard solution to the reference organ
homogenates. The recovery rates determined on
analyses of the reference organ homogenates spiked with
MEHP at the level of 100 μg/g were 92.7% for testis,
93.1% for liver, 87.6% for kidneys and 90.9% for pancreas. In control mice, no MEHP were detected in
all four organs.
2.8 Measurement of NOx in DEHP-treated mice
Samples of testis, liver, kidney and pancreas tissues
were homogenized in 10 volumes of 0.1 mol/L phosphate buffer (pH 7.4) containing 50% methanol. The
homogenates were centrifuged 10 000 ×
g for 20 min at 4ºC, and then the supernatants were centrifuged again to
remove the pellets. The final supernatants were assayed
for NOx with an HPLC-UV system (ENO-10, NOD-10; EICOM, Kyoto, Japan) according to the method used by
Lu et al. [13]. Samples were injected into the
HPLC-UV system at 10-min intervals. Detection was carried
out at 540 nm (absorption), and their concentrations
were calculated from the area under the curve for
NaNO2 or NaNO3 (Powerchrome; EICOM). The
minimal detectable concentration for each NO metabolite
was 1 pmol. NOx concentration of control mice was
less than 10 pmol/10 ìL in all four organs.
2.9 Statistical analysis
Statistical tests were conducted using
Statveiw-J-4.5 (Abacus Concepts, Berkeley, CA, USA). Data were
presented as means ± SE, and were analyzed by means of
paired t-test or one-way ANOVA. Differences were
considered significant if the P < 0.05.
3 Results
DEHP-treated mice had mild diarrhea for 10 days,
and their bodyweights were significantly decreased
(Table 1). The relative liver weights of DEHP-treated
mice were significantly higher than those of control
mice, showing the presence of hepatomegaly (Figure
1). The relative testis weights of DEHP-treated mice
were not significantly changed from those of the controls, neither were the kidney or pancreas weights.
However, histologically, it was noted that most germ
cells had been deleted from the seminiferous epithelium
with much fluid in the tubules of the all DEHP-treated
mice (Figure 2). Histochemically, lipid peroxidation was
detected in the testis but not liver, kidneys or pancreas
of all DEHP-treated mice (Figure 2).
Serum analyses showed a significant decrease in
testosterone, indicating the presence of Leydig cell
dysfunction. It was also found that total protein, BUN,
Na, ALP and GPT in DEHP-treated mice had been increased, indicating the presence of dehydration and
hepatic insufficiency (Figure 3). The BUN / CRE ratios
in control and DEHP-treated mice were 83.6 ± 3.8 (mean
± SE, n = 5) and 89.0 ± 8.6 (mean ± SE,
n = 7), respectively (P < 0.6). Therefore, renal insufficiency was not
apparent in DEHP-treated mice.
As expected, MEHP was specifically accumulated in the livers of DEHP-treated mice (Figure 4). It was
noted that the MEHP concentration in their kidneys was
as high as that in their livers, despite no significant
induction of renal failure. In sharp contrast, the MEHP
concentration in their injured testes was found to be
extremely low. The NOx concentration in livers was
significantly higher than that in kidneys or pancreata in
DEHP-treated mice (Figure 4). However, the testicular
NOx concentration did not significantly differ from that
in the liver, although the testes contained only a small
amount of MEHP.
The testicular concentrations of Zn, Fe and Cu in
DEHP-treated mice were 9.27 ± 0.73 μg/g, 15.47 ± 0.84
μg/g and 1.31 ± 0.12 μg/g, respectively. These were lower than
those in control testes, but the differences between
control and experimental groups were not significant
(P > 0.05, Figure 5).
4 Discussion
In the present study, we showed that the concentration of MEHP in the testes of DEHP-treated mice
was significantly lower than that in the liver, however,
the quantity of the testicular NOx was as high as
hepatic NOx. Furthermore, free radical-induced lipid
peroxidation could be histochemically detected only in
the testes among the four examined organs. These
results suggest that DEHP-induced aspermatogenesis might
due to the high sensitivity of the testicular tissues to
MEHP instead of specific accumulation or uptake of
MEHP into the testis.
In the serum analyses, the concentration of
testosterone was found to significantly decreased in DEHP-treated
mice, indicating the presence of Leydig cell dysfunction.
Furthermore, liver dysfunction with increased GPT and
ALP concentrations was detected in the treated mice.
These findings were consistent with results of previous
studies [4]. It was also noted during the BUN/CRE
analysis that no apparent renal dysfunction was induced in
spite of the high MEHP concentration in the kidneys of
DEHP-treated mice. In contrast, the amount of the
testicular MEHP was found to be extremely low compared
with that in other organs examined, although the
MEHP-toxicity had been exerted on a number of cells including
Sertoli cells, Leydig cells and germ cells [14]. This
indicates that the testicular cells have a quite high sensitivity
to MEHP.
To our knowledge, there has only been one previous
study on free radical production in DEHP-treated animals,
which showed the increased production of reactive oxygens
(O2- and H2O2) in the rat testes, but no other
organs were examined [4]. In the present study, we
compared NOx generation in testes with that in livers,
kidneys and pancreata. The analysis showed that
testicular NOx was as high as hepatic NOx. Therefore,
NOx generation and the MEHP distribution were not
correlated with each other among the four examined organs.
Additionally, we measured the testicular amounts of
Fe, Cu and Zn, the important components of antioxidant
enzymes such as Cu/Zn-SOD, Fe-SOD, Fe/Zn-SOD and catalase (Fe-catalase). These three elements were found
to be slightly, but not significantly, decreased in
DEHP-treated mice. Interestingly, a previous study showed
that the activities of Cu/Zn-SOD and catalase were
significantly increased in DEHP-treated testes [4]. It was
also noted in another study that the Zn concentration
was significantly decreased, whereas the activity of
Zn-containing enzymes (alcohol dehydrogenase and aldolase) was increased in the testes of DEHP-treated
rats [2]. Therefore, it is likely that Zn-related enzymes,
including SOD, are activated by DEHP exposure to a
certain degree in the testis, although the total amount of
Zn in the organ is decreased. With regard to the
non-enzymatic antioxidant system, it was shown that DEHP
administration decreases glutathione, ascorbic acid
(vitamin C) and vitamin E in rat testes [4, 15]. Actually,
our previous study showed that the administration of
vitamins C and E is effective for the prevention and
treatment of DEHP-induced aspermatogenesis [7, 8].
It was also reported that antioxidant vitamins protect
spermatogenesis from other toxic agents [16]. In
contrast to antioxidant vitamins, the administration of Zn
had failed to protect the testes from DEHP-induced
injury [17]. This indicates that the testicular toxicity of
DEHP is the result of the generation of free radicals
rather than depletion of Zn in the testes. In regard to
the effect of administration of testosterone on
DEHP-treated animals, there are two studies: one showed the
protection of spermatogenesis by testosterone [18], but
the other displayed no significant effect on the
spermatogenic disturbance [19].
Inoue et al. [20] reported that mild oxidative stress
to the result of a nephrotoxic agent induced free radical
generation accompanied by an increase in the hepatorenal
glutathione levels in rats. It was also noted that DEHP
administration significantly increased the glutathione
concentration in both livers and kidneys but decreased it in
the testis [4]. Therefore, it could be the high sensitivity
of testicular tissues to DEHP that partially causes the
lowered glutathione levels in testes. In contrast, the
antioxidant hepatorenal glutathione activity might be
relatively resistant to DEHP exposure. Experimental
supplementation of glutathione is now in progress to determine
whether it is useful for the prevention or curation of
DEHP-induced aspermatogenesis.
Acknowledgment
The authors wish to thank Mrs Miyuki Kitaoka, Mrs
Yuki Ogawa and Mrs Fumiko Komoda for their excellent
secretarial and technical supports. This work was
supported by a Grant-in-Aid for General Scientific Research
(17591704) from the Ministry of Education, Science,
Sports and Culture, Japan.
References
1 Gray TJ, Butterworth KR, Gaunt IF, Grasso GP, Gangolli
SD. Short-term toxicity study of di-(2-ethylhexyl) phthalate
in rats. Food Cosmet Toxicol 1977; 15: 389_99.
2 Oishi S. Testicular atrophy induced by di(2-ethyhexlyl)
phthalate: changes in histology, cell specific enzyme activities
and zinc concentrations in rat testis. Arch Toxicol 1986; 59:
290_5.
3 Oishi S, Hiraga K. Effect of phthalic acid esters on mouse
testes. Toxicol Lett 1980; 5: 413_6.
4 Kasahara E, Sato EF, Miyoshi M, Konaka R, Hiramoto K,
Sasaki J, et al. Role of oxidative stress in germ cell apoptosis
induced by di (2-ethylhexyl) phthalate. Biochem J 2002; 365:
849_56.
5 Said TM, Aziz N, Sharma RK, Lewis-Jones I, Thomas AJ Jr,
Agarwal A. Novel association between sperm deformity
index and oxidative stress-induced DNA damage in infertile male
patients. Asian J Androl 2005; 7: 121_6.
6 Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N
Engl J Med 1993; 329: 2002_12.
7 Ablake M, Itoh M, Terayama H, Hayashi S, Shoji S, Naito M,
et al. Di-(2-ethylhexyl) phthalate induces severe
aspermato-genesis in mice, however, subsequent antioxidant vitamins
supplementation accelerates regeneration of the seminiferous
epithelium. Int J Androl 2004; 27: 274_81.
8 Ishihara M, Itoh M, Miyamoto K, Suna S, Takeuchi Y,
Takenaka I, et al. Spermatogenic disturbance induced by
di-(2-ethylhexyl) phthalate is significantly prevented by
treatment with antioxidant vitamins in the rat. Int J Androl 2000;
23: 85_94.
9 Pompella A, Maellaro E, Casini AF, Comporti M.
Histochemical detection of lipid peroxidation in the liver of
bromobenzene-poisoned mice. Am J Pathol 1987; 129: 295_301.
10 Verjans HL, Cooke BA, de Jong FH, de Jong CM, Vander der
Molen HJ. Evaluation of a radioimmunoassay for
testosterone estimation. J Steroid Biochem 1973; 4: 665_76.
11 Kojima I, Kato A, Lida C. Microwave digestion of
biological samples with an acid mixture in a closed double PTFE
vessel for metal determination by "one-drop" flame atomic
absorption spectrometry. Anal Chim Acta 1992; 264:
101_6.
12 Cobellis L, Latini G, De Felice C, Razzi S, Paris I, Ruggieri F,
et al. High plasma concentrations of
di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum Reprod 2003; 18:
1512_5.
13 Lu X, Kassab GS. Nitric oxide is significantly reduced in
ex vivo porcine arteries during reverse flow because of increased
superoxide production. J Physiol 2004; 561: 575_82.
14 Ono H, Saito Y, Imai K, Kato M. Subcellular distribution of
di-(2-ethylhexyl) phthalate in rat testis. J Toxicol Sci 2004;
29: 113_24.
15 Manojkumar V, Padmakumaran Nair KG, Santhosh A,
Deepadevi KV, Arun P, Lakshmi LR, et al. Decrease in the
concentration of vitamin E in blood and tissues caused by di-
(2-ethylhexyl) phthalate, a commonly used plasticizer in blood
storage bags and medical tubing. Vox Sang 1998; 75: 139_44.
16 Bustos-Obregon E, Yucra S, Gonzales GF.
Lepidium meyenii (Maca) reduces spermatogenic damage induced by a single
dose of malathion in mice. Asian J Androl 2005; 7: 71_6.
17 Oishi S, Hiraga K. Testicular atrophy induced by
di-2-ethylhexyl phthalate: effect of zinc supplement. Toxicol Appl
Pharmacol 1983; 70: 43_8.
18 Parmar D, Srivastava SP, Singh GB, Seth PK. Effect of
testosterone on the testicular atrophy caused by di (2-ethylhexyl)
phthalate (DEHP). Toxicol Lett 1987; 36: 297_308.
19 Oishi S. Effects of co-administration of di-(2-ethylhexyl)
phthalate and testosterone on several parameters in the testis
and pharmacokinetics of its mono-de-esterified metabolite.
Arch Toxicol 1989; 63: 289_95.
20 Inoue M, Nobukuni Y, Ando Y, Hirota M, Hirata E, Morino
Y. Interorgan metabolism of glutathione as the defence
mechanism against oxidative stress. Dev Toxicol Environ Sci 1986;
14: 51_60. |